The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms
Open accessAbstract
Objective: To investigate whether the motor and neuroprotective effects of adenosine A 2A receptor (A 2A R) antagonists are mediated by distinct cell types in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) model of Parkinson's disease. Methods: We used the forebrain A 2A R knock‐out mice coupled with flow cytometric analyses and intracerebroventricular injection to determine the contribution of A 2A Rs in forebrain neurons and glial cells to A 2A R antagonist‐mediated motor and neuroprotective effects. Results: The selective deletion of A 2A Rs in forebrain neurons abolished the motor stimulant effects of the A 2A R antagonist KW‐6002 but did not affect acute MPTP neurotoxicity. Intracerebroventricular administration of KW‐6002 into forebrain A 2A R knock‐out mice reinstated protection against acute MPTP‐induced dopaminergic neurotoxicity and attenuated MPTP‐induced striatal microglial and astroglial activation. Interpretation: A 2A R activity in forebrain neurons is critical to the control of motor activity, whereas brain cells other than forebrain neurons (likely glial cells) are important components for protection against acute MPTP toxicity. Ann Neurol 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Cited by
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
Self-citationHow does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Self-citationAdenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Self-citationKaster, M. P., Machado, N. J., Silva, H. B., Nunes, A., Ardais, A. P., Santana, M., Baqi, Y., Müller, C. E., Rodrigues, A. L. S., Porciúncula, L. O., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423088112 · Cited by 312
Self-citationAdenosine signaling and function in glial cells
Boison, D., Chen, J.-F., & Fredholm, B. B. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.131 · Cited by 306
Self-citation
Metadata
- Authors
- Yu, L., Shen, H., Coelho, J. E., Araújo, I. M., Huang, Q., Day, Y., Rebola, N., Canas, P. M., Rapp, E. K., Ferrara, J., Taylor, D., Müller, C. E., Linden, J., Cunha, R. A., & Chen, J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 63
- Issue
- 3
- Pages
- 338-346
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2008871586
- Cited by
- 160
- References
- 5
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. https://app.cochat.ai/papers/10.1002/ana.21313
- The paper
- Yu, L., Shen, H., Coelho, J. E., Araújo, I. M., Huang, Q., Day, Y., Rebola, N., Canas, P. M., Rapp, E. K., Ferrara, J., Taylor, D., Müller, C. E., Linden, J., Cunha, R. A., & Chen, J. (2008). Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Annals of Neurology. https://doi.org/10.1002/ana.21313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.